Hanna Kampling1, Frank Petrak2,3, Erik Farin4, Bernd Kulzer5,6, Stephan Herpertz2, Oskar Mittag4. 1. Section of Health Care Research and Rehabilitation Research, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetterstr. 49, 79106, Freiburg, Germany. hanna.kampling@uniklinik-freiburg.de. 2. Department of Psychosomatic Medicine and Psychotherapy, LWL-University Clinic Bochum - Ruhr-University Bochum, Bochum, Germany. 3. Center for Psychotherapy Wiesbaden, Wiesbaden, Germany. 4. Section of Health Care Research and Rehabilitation Research, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetterstr. 49, 79106, Freiburg, Germany. 5. Diabetes Center Mergentheim, Germany; Research Institute of the Diabetes Academy Mergentheim, Bad Mergentheim, Germany. 6. Department of Clinical Psychology and Psychotherapy, Otto-Friedrich-University of Bamberg, Bamberg, Germany.
Abstract
AIMS/HYPOTHESIS: There is a paucity of longitudinal data on type 1 diabetes and depression, especially in adults. The present study prospectively analysed trajectories of depressive symptoms in adults during the first 5 years of living with type 1 diabetes. We aimed to identify distinct trajectories of depressive symptoms and to examine how they affect diabetes outcome. METHODS: We reanalysed data from a prospective multicentre observational cohort study including 313 adults with newly diagnosed type 1 diabetes. At baseline and in annual postal surveys over 5 consecutive years, we gathered patient characteristics and behavioural and psychosocial data (e.g. Symptom Checklist-90-R [SCL-90-R]). Medical data (e.g. HbA1c levels) was obtained from the treating physicians. We applied growth mixture modelling (GMM) to identify distinct trajectories of depression over time. RESULTS: Five years after diagnosis, 7.8% (n = 20) of patients were moderately depressed and 10.2% (n = 26) were severely depressed. GMM statistics identified three possible models of trajectories (class 1, 'no depressive symptoms'; class 2, 'worsening depressive symptoms that improve after 2 years'; class 3, 'worsening depressive symptoms'). Severity of depression symptoms at baseline (subscale of the SCL-90-R questionnaire) significantly predicted membership of classes 2 and 3 vs class 1. After 5 years, higher HbA1c values were detected in class 3 patients (mean = 8.2%, 66 mmol/mol) compared with class 1 and class 2 (both: mean = 7.2%, 55 mmol/mol). CONCLUSIONS/ INTERPRETATION: We identified distinct trajectories of depressive symptoms that are also relevant for diabetes outcome. Patients with worsening depressive symptoms over time exhibited poor glycaemic control after the first 5 years of living with diabetes. They also exhibited a reduced quality of life and increased diabetes-related distress.
AIMS/HYPOTHESIS: There is a paucity of longitudinal data on type 1 diabetes and depression, especially in adults. The present study prospectively analysed trajectories of depressive symptoms in adults during the first 5 years of living with type 1 diabetes. We aimed to identify distinct trajectories of depressive symptoms and to examine how they affect diabetes outcome. METHODS: We reanalysed data from a prospective multicentre observational cohort study including 313 adults with newly diagnosed type 1 diabetes. At baseline and in annual postal surveys over 5 consecutive years, we gathered patient characteristics and behavioural and psychosocial data (e.g. Symptom Checklist-90-R [SCL-90-R]). Medical data (e.g. HbA1c levels) was obtained from the treating physicians. We applied growth mixture modelling (GMM) to identify distinct trajectories of depression over time. RESULTS: Five years after diagnosis, 7.8% (n = 20) of patients were moderately depressed and 10.2% (n = 26) were severely depressed. GMM statistics identified three possible models of trajectories (class 1, 'no depressive symptoms'; class 2, 'worsening depressive symptoms that improve after 2 years'; class 3, 'worsening depressive symptoms'). Severity of depression symptoms at baseline (subscale of the SCL-90-R questionnaire) significantly predicted membership of classes 2 and 3 vs class 1. After 5 years, higher HbA1c values were detected in class 3 patients (mean = 8.2%, 66 mmol/mol) compared with class 1 and class 2 (both: mean = 7.2%, 55 mmol/mol). CONCLUSIONS/ INTERPRETATION: We identified distinct trajectories of depressive symptoms that are also relevant for diabetes outcome. Patients with worsening depressive symptoms over time exhibited poor glycaemic control after the first 5 years of living with diabetes. They also exhibited a reduced quality of life and increased diabetes-related distress.
Authors: Frank Petrak; Harald Baumeister; Timothy C Skinner; Alex Brown; Richard I G Holt Journal: Lancet Diabetes Endocrinol Date: 2015-05-17 Impact factor: 32.069
Authors: F Pouwer; P H L M Geelhoed-Duijvestijn; C J Tack; E Bazelmans; A-J Beekman; R J Heine; F J Snoek Journal: Diabet Med Date: 2010-02 Impact factor: 4.359
Authors: Frank Petrak; Stephan Herpertz; Christian Albus; Norbert Hermanns; Christoph Hiemke; Wolfgang Hiller; Kai Kronfeld; Johannes Kruse; Bernd Kulzer; Christian Ruckes; Daniela Zahn; Matthias J Müller Journal: Diabetes Care Date: 2015-02-17 Impact factor: 19.112
Authors: Christina M van der Feltz-Cornelis; Jasper Nuyen; Corinne Stoop; Juliana Chan; Alan M Jacobson; Wayne Katon; Frank Snoek; Norman Sartorius Journal: Gen Hosp Psychiatry Date: 2010-05-15 Impact factor: 3.238
Authors: Eva O Melin; Maria Thunander; Ralph Svensson; Mona Landin-Olsson; Hans O Thulesius Journal: Eur J Endocrinol Date: 2013-05-02 Impact factor: 6.664
Authors: Magdalena Beran; Rutendo Muzambi; Anouk Geraets; Juan Rafael Albertorio-Diaz; Marcel C Adriaanse; Marjolein M Iversen; Andrzej Kokoszka; Giesje Nefs; Arie Nouwen; Frans Pouwer; Jörg W Huber; Andreas Schmitt; Miranda T Schram Journal: Diabet Med Date: 2021-09-05 Impact factor: 4.213
Authors: Paola Gilsanz; Andrew J Karter; Michal Schnaider Beeri; Charles P Quesenberry; Rachel A Whitmer Journal: Diabetes Care Date: 2017-12-18 Impact factor: 19.112
Authors: Sascha Ketelhut; Emanuel Wehlan; Gerhart Bayer; Reinhard G Ketelhut Journal: Int J Environ Res Public Health Date: 2022-08-10 Impact factor: 4.614